ADNP Exhibits Methyltransferase Activity in Overexpression Systems and Modulates DNA and Histone Methylation.
ADNP variants tied to autism can add methylation tags that silence other genes—useful lab insight, not a therapy.
01Research in Context
What this study did
D'Incal et al. (2025) looked at the ADNP gene in lab dishes. They asked: can this gene add tiny chemical tags to DNA and to the spools that wrap DNA?
These tags, called methyl groups, act like on-off switches for genes. The team used cells that make extra ADNP to see if the tags changed.
What they found
The gene did the tagging. More ADNP meant more methylation on both DNA and histones.
This is a first look at how an autism-linked gene can flip epigenetic switches.
How this fits with other research
da Silva Montenegro et al. (2020) pooled over 20 000 autism cases and already listed ADNP as a top gene. Peter’s lab work now shows why that gene matters—it can silence other genes by tagging them.
Mukherjee et al. (2015) warned that gene discoveries are useless without clear behavior data. Peter’s study answers the “how” but not the “what you see” part. It extends the 2015 call by giving clinicians a concrete methylation marker to watch.
Niego et al. (2021) found shared blood-gene signals between autism and Williams syndrome. Peter’s methylation marks could be another blood test layer to tell the two groups apart.
Why it matters
You can’t train methylation away, but you can track it. If a child has an ADNP variant, ask the medical team for epigenetic screening. Pair those data with your VB-MAPP or AFLS scores. Over time we may learn which behaviors track with heavy tagging, guiding smarter goals and earlier medical referrals.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Flag any client with an ADNP note in the genetic report and share Peter’s paper with the medical team to request methylation screening.
02At a glance
03Original abstract
Activity-Dependent Neuroprotective Protein (ADNP) is a putative transcription factor that differentially interacts with proteins involved in chromatin remodeling, thereby controlling neuronal differentiation. The protein contains nine zinc fingers, a bipartite nuclear localization signal (NLS), and a homeobox domain with a heterochromatin protein 1 interaction motif, ensuring nuclear association with DNA and chromatin. De novo variants in ADNP cause autism comorbid with intellectual disability in the Helsmoortel-Van der Aa syndrome. ADNP interacts with components of the SWI/SNF in HEK293T cells but has also been reported as part of the repressive ChAHP complex in mouse embryonic stem cells. Although converging evidence suggests a role in chromatin remodeling, Hi-C experiments failed to detect major alterations in 3D chromatin structure. We therefore investigated ADNP's role in epigenetic regulation and identified the chromatin scaffolding protein WDR5 and HDAC2 as interaction partners. Structural modeling revealed two N-terminal methyltransferase domains, suggesting catalytic activity via SAM to SAH conversion. Immunoprecipitated fractions containing wild-type ADNP exhibited methyltransferase activity, which was reduced by nonsense variants. ADNP was expressed in histone-enriched cerebellar fractions in mice and a Helsmoortel-Van der Aa autopsy case, with male-specific reduction of the H3K79me1 modification. At the DNA level, wild-type ADNP induced CpG hypermethylation. However, most variants caused CpG hypomethylation, supporting a loss-of-function mechanism, while NLS variants showed additional hypermethylation, suggesting a gain-of-function effect linked to apoptosis and microtubule transport. Taken together, we identified an ADNP-WDR5-HDAC2 protein complex involved in epigenetic regulation, with ADNP exhibiting methyltransferase activity in overexpression systems.
Autism research : official journal of the International Society for Autism Research, 2025 · doi:10.1002/aur.70132